Scoping review of the current landscape of AI-based applications in clinical trials

BACKGROUND: Clinical trials are essential for bringing new drugs, technologies and procedures to the market and clinical practice. Considering the design and the four-phase development, only 10% of them complete the entire process, partly due to the increasing costs and complexity of clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Cascini, Fidelia, Beccia, Flavia, Causio, Francesco Andrea, Melnyk, Andriy, Zaino, Andrea, Ricciardi, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414344/
https://www.ncbi.nlm.nih.gov/pubmed/36033816
http://dx.doi.org/10.3389/fpubh.2022.949377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414344/
https://www.ncbi.nlm.nih.gov/pubmed/36033816
http://dx.doi.org/10.3389/fpubh.2022.949377

Ejemplares similares